Mitoxantrone hydrochloride liposome (Lipo-MIT) combined with capecitabine in HER2-negative advanced breast cancer: a dose-escalation, phase I study.

BMC Med · 2026 · PMC13267627 · PMID 42050512

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

In this post hoc, exploratory evaluation, there appeared to be a numerical trend toward deeper responses in the Q4W cohort, with several patients maintaining tumor shrinkage for an extended period.

also in 723 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.